Circulating microparticle effects on phenotypically distinct pulmonary endothelium

循环微粒对表型不同的肺内皮的影响

基本信息

  • 批准号:
    9256870
  • 负责人:
  • 金额:
    $ 37.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2021-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Pulmonary artery and capillary endothelial cells are structurally and functionally heterogeneous in multiple ways including their inflammatory response. In pulmonary arterial hypertension (PAH), CD68-positive monocytes accumulate around arterioles as opposed to migrating into the alveolar space as they do in acute lung injury. Further, inflammatory infiltrates are a feature of late-stage disease, are localized to small arterioles, and are not as observable in the early stages of PAH. The contributions of the inflammatory cell infiltrates include release of growth factors and further inflammatory stimuli. The precise mechanisms that influence the temporal recruitment of inflammatory cells to the perivascular space in select size vessels and the influence of the phenotypically distinct endothelium remain unknown. Microparticle signaling within phenotypically distinct endothelium has not been considered and could have significant implications toward adhesion molecule expression. We found that microparticles from late-stage PAH rats were endocytosed and localized to the perinuclear space in pulmonary artery endothelial cells (PAECs), induced adhesion molecule expression, and promoted leukocyte adhesion. However, none of these events occurred in pulmonary microvascular endothelium (PMVECs) with the same treatment. Further, microparticles isolated from the circulation of early- stage PAH rats had none of these effects on either cell type. To determine the mechanism of microparticle signaling in the PAECs we examined Rab proteins responsible for vesicle trafficking and intracellular localization. RNAseq analysis and RT-PCR of PAECs and PMVECs revealed Rab36 is expressed only in the PAECs. Rab36 is a newly identified RabGTPase responsible for retrograde transport of vesicles to the Golgi and nucleus. Based on these data this proposal tests the overall HYPOTHESIS that late-stage microparticles, circulating in PAH, increase adhesion molecule expression selectively in the pulmonary arteries dependent on Rab36. SPECIFIC AIMS test the hypotheses that circulating microparticles obtained from late-stage, but not early-stage PAH: 1. Stimulate expression and activity of adhesion molecules selectively in the pulmonary artery. 2. Are dependent on Rab36 for uptake and subcellular localization in the pulmonary artery.
项目摘要 肺动脉和毛细血管内皮细胞在结构和功能上是异质的, 包括炎症反应。在肺动脉高压(PAH)中,CD 68阳性 单核细胞聚集在小动脉周围,而不是像急性炎症中那样迁移到肺泡腔中。 肺损伤此外,炎性浸润是晚期疾病的特征,局限于小动脉, 在PAH的早期阶段并不明显。炎症细胞浸润的贡献 包括释放生长因子和进一步炎症刺激。影响人类行为的精确机制 炎性细胞在选定大小血管中暂时聚集到血管周围空间以及 表型上不同的内皮仍然是未知的。表型不同的细胞内的微粒信号传导 内皮细胞尚未被考虑,可能对粘附分子有重要意义 表情我们发现晚期PAH大鼠的微粒被内吞并定位于 肺动脉内皮细胞(PAECs)核周间隙,诱导粘附分子表达, 促进白细胞粘附。然而,这些事件均未发生在肺微血管 内皮细胞(PMVEC),用相同的治疗。此外,从早期-晚期的循环中分离的微粒, 阶段PAH大鼠对两种细胞类型都没有这些影响。为了确定微粒的作用机理, 我们检测了负责囊泡运输和细胞内信号传导的Rab蛋白, 本地化PAEC和PMVEC的RNAseq分析和RT-PCR显示Rab 36仅在 PAEC。Rab 36是一个新发现的RabGT酶,负责囊泡向高尔基体的逆行转运 和核。基于这些数据,该提案测试了后期阶段的总体假设, 在PAH中循环的微颗粒,选择性地增加粘附分子在肺动脉中的表达。 肺动脉依赖Rab 36。特定目标测试的假设, 从晚期而非早期PAH获得的微粒:1.刺激表达和活动 粘附分子在肺动脉中的选择性。2.依赖于Rab 36的摄取, 肺动脉中的亚细胞定位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Natalie Norwood Bauer其他文献

Natalie Norwood Bauer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Natalie Norwood Bauer', 18)}}的其他基金

Myoendothelial Junction and Microparticle Stimulation of PAH Vascular Lesions
肌内皮连接和微粒刺激 PAH 血管病变
  • 批准号:
    8211913
  • 财政年份:
    2011
  • 资助金额:
    $ 37.88万
  • 项目类别:
Myoendothelial Junction and Microparticle Stimulation of PAH Vascular Lesions
肌内皮连接和微粒刺激 PAH 血管病变
  • 批准号:
    8335472
  • 财政年份:
    2011
  • 资助金额:
    $ 37.88万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
  • 批准号:
    MR/Y000404/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.88万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了